This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove Patient Advocacy Remove Pharmaceutical Industry Related Topics
COVID-19 Vaccine Health Outcomes FDA COVID-19 Nurses More Related Topics >
article thumbnail

How the Life Sciences Industry Can Boost Diversity and Inclusion Efforts

HIT Consultant

MAY 2, 2022

The pharmaceutical industry differs in many ways from other industries. To change this, life science and pharmaceutical companies should: – Convene a high-level steering committee of top KOLs and representatives of patient advocacy groups who are passionate about diversity.

COVID-19 Vaccine 96
COVID-19 Vaccine Patient Advocacy Pharmaceutical Industry COVID-19 96
article thumbnail

Pharmaceutical Industry Funding to Patient-Advocacy Organizations: A Cross-National Comparison of Disclosure Codes and Regulation

HealthLaw Prof Blog

FEBRUARY 27, 2024

Pharmaceutical Industry Funding to Patient-Advocacy Organizations: A Cross-National Comparison of Disclosure Codes and Regulation, 42 Hastings Int’l and. Laura Karas (Harvard Law School), Robin Feldman (UC San Francisco), Ge Bai (Johns Hopkins University), So-Yeon Kang (Johns Hopkins University), et al.,

Pharmaceutical Industry 40
Pharmaceutical Industry Patient Advocacy 40
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 50,000+ Insiders by signing up for our newsletter

About
About
Editions
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024